探索免疫供应链的新型包装与递送方案
疫苗包装与递送技术(如吹灌封聚合物容器、皮内递送装置、微阵列贴片、舌下疫苗)可惠及免疫供应链,其上市时间因开发阶段和许可所需数据而异。部分皮内装置预计2017年引入以缓解灭活脊髓灰质炎疫苗供应限制,需重新配方的技术可能2021年后可用。开发需制造商合作与监管路径识别,早期与公立部门利益相关方互动很重要,规划适用性需考虑冷链体积、成本和健康影响。
要点
- 吹灌封聚合物容器、皮内装置、微阵列贴片和舌下疫苗等包装与递送技术可惠及免疫供应链。
- 皮内装置预计2017年引入,用于递送灭活脊髓灰质炎疫苗以缓解供应限制。
- 需疫苗重新配方的技术(微阵列贴片、舌下疫苗)可能2021年及以后可用。
核心结论
- 多种疫苗包装和递送技术可能惠及免疫供应链,其可用时间因开发阶段和许可所需数据而异。
- 许多新技术开发需要疫苗与设备制造商合作并确定适用监管路径。
- 早期通过世界卫生组织免疫实践咨询委员会递送技术工作组等论坛与公立部门利益相关方互动,对确保适合免疫规划使用很重要。
研究设计与样本
- 本文为综述,阐述多种疫苗包装和递送技术的前景、可用时间线及规划适用性考量。
主要发现
- 替代初级包装包括吹灌封聚合物容器,新型递送技术包括皮内递送装置、微阵列贴片和舌下疫苗制剂等。
- 部分新型递送装置预计2017年引入,如用于递送灭活脊髓灰质炎疫苗的皮内装置,以因供应限制而扩大疫苗供应。
- 需要疫苗重新配方的微阵列贴片和舌下疫苗等新技术可能在长期(2021年及以后)可用。
关键数值与推荐
- 新疫苗、包装和递送装置的规划适用性关键考量包括冷链体积、成本和健康影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
A variety of vaccine packaging and delivery technologies may benefit the immunization supply chain. These include alternative primary packaging, such as blow-fill-seal polymer containers, and novel delivery technologies, such intradermal delivery devices, microarray patches, and sublingual formulations of vaccines, and others in development. The potential timeline to availability of these technologies varies and depends on their stage of development and the type of data necessary to achieve licensure. Some new delivery devices are anticipated to be introduced in 2017, such as intradermal devices for delivery of inactivated poliovirus vaccine to stretch vaccine supplies due to a supply limitation. Other new technologies requiring vaccine reformulation, such as microarray patches and sublingual vaccines, may become available in the long term (2021 and beyond). Development of many new technologies requires partnership between vaccine and technology manufacturers and identification of the applicable regulatory pathway. Interaction with public-sector stakeholders early on (through engagement with forums such as the World Health Organization's Immunization Practices Advisory Committee Delivery Technologies Working Group) is important to ensure suitability for immunization program use. Key considerations for programmatic suitability of a new vaccine, packaging, and delivery device include cold chain volume, costs, and health impact.
引用
- Zehrung D, Jarrahian C, Giersing B, et al. Exploring new packaging and delivery options for the immunization supply chain. Vaccine. 2017. PMID: 28364941. doi:10.1016/j.vaccine.2016.11.095
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。